Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Elizabeth Rayne Ars Technica Scribe @arstechnica @denofgeek @unclekrust. the void Writing	Craving carbs? Blame an ancient gene. - about 1 month ago
2	<em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Leveraging Recombinant Kinases for Drug Discovery Research - about 1 month ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender - about 1 month ago Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 7 months ago
4	Shelby Bradford, PhD The Scientist Assistant Editor @TheScientistLLC. Opinions my own. scienceediting	The Regulation of the lac Operon - about 2 months ago
5	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - about 2 months ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - about 2 months ago
7	Kristen Monaco MedPage Today	ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up - about 2 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 6 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 7 months ago Glucose Changes in Type 1 Diabetes May Affect Thinking Speed - 11 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 11 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - about 1 year ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - about 1 year ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - about 1 year ago JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes - about 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - about 1 year ago Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd - about 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - over 1 year ago
8	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Metformin Use Linked to Fewer Asthma Attacks - 2 months ago The GLP-1 Agonist Plateau No One's Talking About - over 1 year ago
9	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - 3 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 3 months ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 6 months ago Teva Launches Generic Formulation of Liraglutide in US - 7 months ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 10 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 11 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 11 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - about 1 year ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago

Journalists covering glucokinase